Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -3.93% |
|
-9.88% | -88.25% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
106M | - | - | - | - | - | |
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |